Plus Therapeutics (PSTV) Misses Q4 EPS by 424c

Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Oregon Pacific Bancorp (ORPB) Tops Q2 EPS by 38c
• Community West Bancshares (CWBC) Misses Q2 EPS by 20c